【译】KRAS基因密码子12和13与无病生存的野生型BRAF的II I期结肠癌辅助化疗试验从一个突变(n0147联盟)。

KRAS codon 12 and 13 mutations in relation to disease-free survival in BRAF-wild type stage III colon cancers from an adjuvant chemotherapy trial (N0147 Alliance).

youdao

没有临床试验时，辅助的化疗和放疗对于个体病人是可以考虑的。

In the absence of a clinical trial adjuvant chemotherapy and radiation therapy may be considered on an individual basis.

youdao

没有临床试验时，辅助的化疗和放疗对于个体病人是可以考虑的。

In the absence of a clinical trial adjuvant chemotherapy and radiation therapy may be considered on an individual basis.

youdao